Recap: GSK Q4 Earnings
Portfolio Pulse from Benzinga Insights
GSK (NYSE:GSK) reported Q4 earnings with an EPS of $0.718, missing the estimate of $0.75 by 4.27%. Revenue increased by $1.41 billion from the same period last year. Despite beating EPS estimates last quarter, GSK's share price dropped by 1.19% the following day.
January 31, 2024 | 10:05 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
GSK reported lower-than-expected Q4 earnings with an EPS miss of 4.27%, but showed a significant increase in revenue compared to last year.
GSK's miss on the EPS estimate is likely to negatively impact investor sentiment in the short term, as historical data shows a share price drop following last quarter's earnings beat. However, the significant increase in revenue may offset some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100